Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial
Authors: Bookman, Michael A | Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology | March 15, 2022 | PubMed abstract
